Stock Quote

Avadel Pharmaceuticals to Participate in Fireside Chats at Upcoming March 2021 Investor Conferences

DUBLIN, Ireland, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that members of the Avadel management team will participate in fireside chats at the H.C. Wainwright Global Life Sciences Conference and Oppenheimer 31st Annual Healthcare Conference which are being held in March 2021.

Fireside Chat Details:
Event:H.C. Wainwright Global Life Sciences Conference
Date:March 9th
Webcast:A webcast of this event will be available starting at 7 a.m. ET on Tuesday, March 9th, at (click here), as well as on Avadel’s website, www.avadel.com, with an archive available for 90 days.
  
Event:Oppenheimer 31st Annual Healthcare Conference
Time and Date:3:10 p.m. ET on Wednesday, March 17th  
Webcast:A live webcast of this event, as well as an archived recording, will be available at (click here), as well as on Avadel’s website, www.avadel.com, for 90 days from being made available.

Contacts:

 Tom McHugh
 Chief Financial Officer
 Phone: (636) 449-1843
 Email: tmchugh@avadel.com
  
 Tim McCarthy
 LifeSci Advisors, LLC
 Phone: (212) 915-2564
 Email: tim@lifesciadvisors.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.